Anheuser-Busch InBev/NV (BUD) Q3 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/10/31/anheuser-busch-inbevnv-bud-q3-2024-earnings-call-t/?source=iedfolrf0000001
Oct 31, 2024 - BUD earnings call for the period ending September 30, 2024.
0
Relay Stock Soars on Upbeat Data From Breast Cancer Study
https://www.zacks.com/stock/news/2334138/relay-stock-soars-on-upbeat-data-from-breast-cancer-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334138
Sep 10, 2024 - RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for treating MBC.
0
Bayer Reports Encouraging NSCLC Drug Data, Gets Approval for Eylea 8mg
https://www.zacks.com/stock/news/2334045/bayer-reports-encouraging-nsclc-drug-data-gets-approval-for-eylea-8mg?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334045
Sep 10, 2024 - BAYRY's NSCLC drug BAY 2927088 shows an encouraging safety profile in the expansion part of the ongoing study. The company also announces the approval of Eylea 8mg.
0